SCHEMBL2864978

SCHEMBL2864978

O=C(O)c1ccc2c(c(-c3cc4ccccc4o3)nn2C(c2ccccc2)(c2ccccc2)c2ccccc2)c1F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.46
ALDH1A1 P00352 8/20 0.46
TDP1 Q9NUW8 1/20 0.46
MEN1 O00255 9/20 0.40
KMT2A Q03164 9/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
KDM5A P29375 1/20 0.39
KDM4C Q9H3R0 1/20 0.39
KDM5B Q9UGL1 1/20 0.39
MAPT P10636 4/20 0.38
POLB P06746 2/20 0.38
MAPK1 P28482 1/20 0.38
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA3 P07451 1/20 0.38
TSHR P16473 1/20 0.38
CA4 P22748 1/20 0.38
CA6 P23280 1/20 0.38
MAOB P27338 1/20 0.38
CA5A P35218 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2871263 0.90 KDM4E (0.41) KDM4EALDH1A1TDP1MEN1KMT2A
SCHEMBL2870712 0.85 ALDH1A1 (0.36) KDM4EALDH1A1TDP1MEN1KMT2A
SCHEMBL2864981 0.83 KDM4E (0.39) KDM4EALDH1A1TDP1MEN1KMT2A
SCHEMBL2862655 0.81 SRC (0.40) MEN1KMT2ATSHRCYP1A2CYP2C9
SCHEMBL2861505 0.79 MAOB (0.48) KDM4EALDH1A1MEN1KMT2AMAPT
SCHEMBL2855702 0.78 CA12 (0.38) CA12CA1CA4CA5ACA7
SCHEMBL2865256 0.77 PTGER1 (0.41) KDM4EALDH1A1
SCHEMBL2871264 0.74 SLC6A3 (0.35) KDM4EALDH1A1TDP1MEN1KMT2A
SCHEMBL4331301 0.74 KDM4E (0.41) KDM4EALDH1A1TDP1MEN1KMT2A
SCHEMBL4341027 0.73 KDM4E (0.40) KDM4EALDH1A1TDP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-6982274-B2 1H-indazole compound EISAI CO., LTD. (JP) 2006-01-03 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed
US-20040127538-A1 Novel 1h-indazole compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-07-01 US disclosed
EP-1380576-A1 NOVEL 1H-INDAZOLE COMPOUND Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 KDM4E 2531/4885ALDH1A1 1588/4885TDP1 3905/4885
US-20040127538-A1 Novel 1h-indazole compound MAPK1, MAPK14, MAPK3 KDM4E 2430/4885ALDH1A1 1744/4885TDP1 4093/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 KDM4E 2531/4885ALDH1A1 1588/4885TDP1 3905/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.